Gabelli & Co Investment Advisers’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-740,335	Closed	-$12.5M	–	189
2014 Q4	$12.5M	Buy	+740,335	New	+$10.4M	1.8%	20

Gabelli & Co Investment Advisers's AVNR Position: Q1 2015 in Review

Gabelli & Co Investment Advisers sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 740,335 shares — an estimated $12.5M sold.

Gabelli & Co Investment Advisers first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $12.5M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Gabelli & Co Investment Advisers reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 740,335 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $12.5M.
Gabelli & Co Investment Advisers first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
Gabelli & Co Investment Advisers's AVANIR PHARMACEUTICALS, INC CL A position peaked at $12.5M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2015, filed 1 May 2015.